Joseph M. Unger

Also affiliated with SWOG Cancer Research Network

Economics, Econometrics and FinanceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

3.3Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Current Practices for Screening and Addressing Financial Hardship within the NCI Community Oncology Research Program

Cancer Epidemiology Biomarkers & Prevention(2020)10.1158/1055-9965.epi-20-1157

Top 7%

3.3DataRank

Top 7%64 citations

Chandylen L. Nightingale, Emily V. Dressler, Anna C. Snavely, Matthew F. Hudson, Joseph M. Unger +8 more

Papers

Driven by 57 papers — median percentile 47. Top paper: “Current Practices for Screening and Addressing Financial Hardship within the NCI Community Oncology Research Program”.

Current Practices for Screening and Addressing Financial Hardship within the NCI Community Oncology Research Program

Cancer Epidemiology Biomarkers & Prevention(2020)10.1158/1055-9965.epi-20-1157

Top 7%

3.3DataRank

Top 7%64 citations

Chandylen L. Nightingale, Emily V. Dressler, Anna C. Snavely, Matthew F. Hudson, Joseph M. Unger +8 more

Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer

JAMA Oncology(2021)10.1001/jamaoncol.2021.2209

N/A

3.1DataRank · unranked

105 citations

Mary W. Redman, Lyudmila Bazhenova, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz +14 more

Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor–Related Joint Pain

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.41720

N/A

1.5DataRank · unranked

56 citations

Joseph M. Unger, Heather Greenlee, Jillian L. Capodice, Danika L. Lew, Amy K. Darke +5 more

Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae314

N/A

0.443DataRank · unranked

10 citations

William E. Barlow, Julie R. Gralow, Funda Meric‐Bernstam, Kathy S. Albain, Daniel F. Hayes +19 more

Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG)

JCO Clinical Cancer Informatics(2023)10.1200/cci.22.00165

N/A

0.336DataRank · unranked

4 citations

Weijia Fan, Aijin Wang, Riha Vaidya, Mary W. Redman, Scott Gettinger +5 more

S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)

Future Oncology(2025)10.1080/14796694.2025.2485020

N/A

0.176DataRank · unranked

2 citations

Sarah Colby, Paul E. Oberstein, Dan G. Duda, Robin Park, Rajiv Agarwal +12 more

Cumulative incidence of financial hardship in metastatic colorectal cancer patients: Primary endpoint results for SWOG S1417CD.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.7010

N/A

0DataRank · unranked

9 citations

Joseph M. Unger, Amy K. Darke, Jennifer M. Suga, James L. Wade, Peter J. Kourlas +7 more

Predictive model of aromatase inhibitor non-adherence using patient-reported outcomes in women with breast cancer (SWOG S1105).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.12019

N/A

0DataRank · unranked

3 citations

Anna Moseley, Kathryn B. Arnold, Grace Clarke Hillyer, Julie R. Gralow, N. Lynn Henry +4 more

Cumulative incidence of financial hardship in metastatic colorectal cancer (mCRC) patients (pts): Primary endpoint results for SWOG S1417CD.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.29_suppl.137

N/A

0DataRank · unranked

2 citations

Joseph M. Unger, Amy K. Darke, Jennifer M. Suga, James L. Wade, Peter J. Kourlas +7 more

Trends in obesity among patients registered to SWOG cancer clinical treatment trials.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.29_suppl.126

N/A

0DataRank · unranked

2 citations

Cathee Till, Heather Greenlee, Dawn L. Hershman, Joseph M. Unger, Riha Vaidya

Relevance of bone marrow biopsies for response assessment in NCTN follicular lymphoma clinical trials.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8038

N/A

0DataRank · unranked

1 citations

Jun Yin, Levi Pederson, Betsy LaPlant, Mazyar Shadman, Hongli Li +15 more

Feasibility of a digital medicine program in optimizing opioid pain control in cancer patients (SWOG S1916).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps12126

N/A

0DataRank · unranked

0 citations

Riha Vaidya, Amy K. Darke, Joseph M. Unger, Mina S. Sedrak, Barbara Segarra-Vázquez +9 more

The association of patient fatigue and outcomes in advanced cancer: An analysis of four SWOG treatment trials.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.29_suppl.140

N/A

0DataRank · unranked

0 citations

Amy K. Darke, Katherine A. Guthrie, Jeff A. Sloan, Joseph M. Unger, Dawn L. Hershman +4 more

S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab210

N/A

0DataRank · unranked

70 citations

Joseph M. Unger, Amy K. Darke, Jennifer M. Suga, James L. Wade, Peter J. Kourlas +7 more

Cancer Clinical Trial Participation at the 1-Year Anniversary of the Outbreak of the COVID-19 Pandemic

JAMA Network Open(2021)10.1001/jamanetworkopen.2021.18433

N/A

0DataRank · unranked

55 citations

Hong Xiao, Michael LeBlanc, Dawn L. Hershman, Charles D. Blanke, Joseph M. Unger

Patient-Reported Outcomes and Long-Term Nonadherence to Aromatase Inhibitors

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab022

N/A

0DataRank · unranked

26 citations

Alfred I. Neugut, Anna Moseley, Kathryn B. Arnold, Julie R. Gralow, N. Lynn Henry +4 more

Long-term results from a randomized blinded sham- and waitlist-controlled trial of acupuncture for joint symptoms related to aromatase inhibitors in early stage breast cancer (S1200).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.12018

N/A

0DataRank · unranked

2 citations

Joseph M. Unger, Heather Greenlee, Jillian L. Capodice, Danika L. Lew, Amy K. Darke +5 more

Preference-weighted quality of life: Findings from the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Journal of Clinical Oncology(2021)10.1200/jco.2020.39.28_suppl.144

N/A

0DataRank · unranked

0 citations

Riha Vaidya, Cathee Till, Joseph M. Unger, Dawn L. Hershman, Daniel Maeng +2 more

1073P Quality of life (QOL) endpoints from the phase III intergroup S1404 adjuvant melanoma trial

Annals of Oncology(2021)10.1016/j.annonc.2021.08.1458

N/A

0DataRank · unranked

0 citations

Joseph M. Unger, Megan Othus, Amy K. Darke, Ahmad A. Tarhini, John M. Kirkwood +5 more

Trial Design Considerations to Increase Older Adult Accrual to National Cancer Institute Clinical Trials

JNCI Monographs(2022)10.1093/jncimonographs/lgac023

N/A

0DataRank · unranked

29 citations

Supriya G. Mohile, Joseph M. Unger, Matthew F. Hudson, Jared C. Foster, Stuart M. Lichtman +11 more

Trends in Obesity Prevalence Among Patients Enrolled in Clinical Trials for Obesity-Related Cancers, 1986 to 2016

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.34445

N/A

0DataRank · unranked

10 citations

Cathee Till, Heather Greenlee, Dawn L. Hershman, Joseph M. Unger, Riha Vaidya

Access to urologists for participation in research: An analysis of NCI's Community Oncology Research Program landscape survey

Contemporary Clinical Trials Communications(2022)10.1016/j.conctc.2022.100981

N/A

0DataRank · unranked

3 citations

Riha Vaidya, Joseph M. Unger, Kelly Stratton, Jessie Gills, Peter J. Van Veldhuizen +9 more

Tailoring Pain Interference Measurement in People with Cancer: A Feasibility Study

Journal of Pain and Symptom Management(2022)10.1016/j.jpainsymman.2022.02.334

N/A

0DataRank · unranked

2 citations

Joseph M. Unger, Salene M. W. Jones

The Medicaid expansion of the Affordable Care Act and participation of patients with Medicaid in cancer clinical trials.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6505

N/A

0DataRank · unranked

3 citations

Hong Xiao, Riha Vaidya, Dawn L. Hershman, Joseph M. Unger

Socioeconomic deprivation and patient-reported outcomes in symptom management trials for patients with breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.28_suppl.158

N/A

0DataRank · unranked

2 citations

Cathee Till, N. Lynn Henry, Michael Fisch, Dawn L. Hershman, Joseph M. Unger +1 more

Survival outcomes by insurance status for patients with cancer ages 18-64 and 65 or older treated in clinical trials.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.28_suppl.154

N/A

0DataRank · unranked

1 citations

Anna Moseley, Riha Vaidya, Hong Xiao, Michael LeBlanc, Dawn L. Hershman +1 more

Feasibility of a patient-centered method to determine meaningful change in pain intensity on a survey of patients with a history of cancer

PAIN Reports(2022)10.1097/pr9.0000000000001015

N/A

0DataRank · unranked

0 citations

Joseph M. Unger, Salene M. W. Jones

Representativeness of patients enrolled in the Lung Cancer Master Protocol (Lung-MAP).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6543

N/A

0DataRank · unranked

0 citations

Joseph M. Unger, Qian Lü, Katherine Minichiello, Roy S. Herbst, David R. Gandara +14 more

Differences in clinician and patient assessment of baseline neuropathy in patients receiving taxane-based chemotherapy enrolled to SWOG S1714 (NCT# 03939481).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12024

N/A

0DataRank · unranked

0 citations

Joseph M. Unger, Dawn L. Hershman, Amy K. Darke, Daniel L. Hertz, Thomas H. Brannagan +8 more

Assessment of financial screening and navigation capabilities at National Cancer Institute community oncology clinics

JNCI Cancer Spectrum(2023)10.1093/jncics/pkad055

N/A

0DataRank · unranked

15 citations

Kate Watabayashi, Debbie Delaney, Ruth C. Carlos, Shelby L. Langer, Joseph M. Unger +6 more

Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad003

N/A

0DataRank · unranked

8 citations

Qian Lu, Mary W. Redman, Susan S. Tavernier, Lori M. Minasian, Ellen V. Sigal +17 more

Risk prediction of hepatitis B or C or HIV among newly diagnosed cancer patients

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad053

N/A

0DataRank · unranked

1 citations

Cathee Till, Jessica Hwang, Kathryn B. Arnold, Michael LeBlanc, Dawn L. Hershman +2 more

Chemotherapy induced peripheral neuropathy (CIPN) due to paclitaxel versus docetaxel in patients with early-stage breast cancer receiving taxane therapy: SWOG S1714.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12003

N/A

0DataRank · unranked

11 citations

Joseph M. Unger, Dawn L. Hershman, Amy K. Darke, Daniel L. Hertz, Thomas H. Brannagan +9 more

Examining uptake of electronic patient reported outcomes (ePRO) in a prospective study of immune-related adverse events (IR-AEs).

JCO Oncology Practice(2023)10.1200/op.2023.19.11_suppl.368

N/A

0DataRank · unranked

2 citations

Amy K. Darke, Krishna S. Gunturu, Dawn L. Hershman, Michael Fisch, N. Lynn Henry +2 more

S2207: RANDOMIZED PHASE II STUDY OF THE ADDITION OF TARGETED AGENTS TO TAFASITAMAB‐LENALIDOMIDE IN TRANSPLANT INELIGIBLE PATIENTS WITH RELAPSED/REFRACTORY LBCL

Hematological Oncology(2023)10.1002/hon.3166_ot22

N/A

0DataRank · unranked

1 citations

Patrick M. Reagan, H. Li, Hayder Saeed, Riha Vaidya, Joseph M. Unger +5 more

Association of measures of socioeconomic deprivation with healthcare utilization in elderly patients enrolled in SWOG cancer clinical trials.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6527

N/A

0DataRank · unranked

0 citations

Riha Vaidya, Cathee Till, William E. Barlow, Michael LeBlanc, Scott D. Ramsey +2 more

The association of sociodemographic variables with smoking prevalence in patients enrolled on clinical trials.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e13595

Top 100%

0DataRank

Top 100%0 citations

Riha Vaidya, Cathee Till, Kimlin Ashing, Graham Warren, Dawn L. Hershman +13 more

Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0255

N/A

0DataRank · unranked

0 citations

Joseph M. Unger, Rohit Loomba, Jessica Hwang, Rashmi Chugh, Monica A. Tincopa +4 more

Mixed-methods analysis of physician genomic confidence in the pre-implementation phase of the cluster randomized trial evaluating genomic tumor boards (SWOG S2108CD, NCT05455606).

JCO Oncology Practice(2023)10.1200/op.2023.19.11_suppl.439

N/A

0DataRank · unranked

0 citations

Jens Rueter, Joseph M. Unger, Kathryn B. Arnold, Sarah Colby, Alissa Michel +8 more

Socioeconomic Deprivation and Health Care Use in Patients Enrolled in SWOG Cancer Clinical Trials

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.4008

N/A

0DataRank · unranked

13 citations

Riha Vaidya, Cathee Till, William E. Barlow, Mike LeBlanc, Scott D. Ramsey +2 more

Smoking prevalence and association with sociodemographic variables in cancer clinical trial participants

Cancer(2024)10.1002/cncr.35560

N/A

0DataRank · unranked

2 citations

Cathee Till, Riha Vaidya, Kimlin Ashing, Graham Warren, Virginia Sun +11 more

The cost of doing business: Drug costs in federally sponsored cancer clinical trials.

JCO Oncology Practice(2024)10.1200/op.2024.20.10_suppl.10

N/A

0DataRank · unranked

2 citations

Hong Xiao, Riha Vaidya, Sara Ashley Threlkel, Matthew Chansky, Allison Hayes +3 more

Cancer in rural America: Improving access to clinical trials and quality of oncologic care

CA A Cancer Journal for Clinicians(2025)10.3322/caac.70006

N/A

0DataRank · unranked

15 citations

Barbara Mcaneny, Raymond U. Osarogiagbon, Joseph M. Unger

Best practices and pragmatic approaches for patient-reported outcomes and quality of life measures in cancer clinical trials

JNCI Monographs(2025)10.1093/jncimonographs/lgae047

N/A

0DataRank · unranked

7 citations

Pedro A. Torres‐Saavedra, Eva Culakova, Heather Gunn, Minji K. Lee, Fenghai Duan +5 more

When to adjust for multiplicity in cancer clinical trials

JNCI Monographs(2025)10.1093/jncimonographs/lgae051

N/A

0DataRank · unranked

2 citations

Gina L. Mazza, Mohamed I. Elsaid, Fenghai Duan, Emily V. Dressler, Anna C. Snavely +3 more

Practical design considerations for cluster randomized controlled trials: lessons learned in community oncology research

JNCI Monographs(2025)10.1093/jncimonographs/lgae053

N/A

0DataRank · unranked

1 citations

Stephanie L. Pugh, Heather Gunn, Joseph M. Unger, David M. Zahrieh, Anna C. Snavely +1 more

Design and analysis considerations for investigating patient subgroups of interest within cancer clinical trials

JNCI Monographs(2025)10.1093/jncimonographs/lgae045

N/A

0DataRank · unranked

1 citations

Eva Culakova, Danielle Enserro, James J. Dignam, Joseph M. Unger, Gina L. Mazza

Acute Toxicity in SWOG 1706, a Randomized Trial Comparing Radiotherapy for Inflammatory Breast Cancer with and without Concurrent Olaparib

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.06.1169

N/A

0DataRank · unranked

0 citations

Allison Meisner, Pavani Chalasani, W. Barlow, Jennifer R. Bellon, N. Lynn Henry +14 more

Changes in the commercially insured cancer patient population following implementation of the Affordable Care Act in Washington state.

JCO Oncology Practice(2025)10.1200/op.2025.21.10_suppl.241

N/A

0DataRank · unranked

0 citations

Winona Wright, Li Li, Catherine R. Fedorenko, Joseph M. Unger, Karma L. Kreizenbeck +2 more

Composition of health care contact days and mortality prediction among trial participants.

JCO Oncology Practice(2025)10.1200/op.2025.21.10_suppl.454

N/A

0DataRank · unranked

0 citations

Cathee Till, Michael LeBlanc, Dawn L. Hershman, Joseph M. Unger, Arjun Gupta

Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies

JNCI Cancer Spectrum(2020)10.1093/jncics/pkaa034

N/A

0DataRank · unranked

114 citations

Dawn L. Hershman, Raymond U. Osarogiagbon, Anirudh Gothwal, Seerat Anand, Arvind Dasari +4 more

Race and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in the Randomized RxPONDER Trial

UNC Libraries(2025)10.17615/dgtt-ap31

N/A

0DataRank · unranked

0 citations

Julie R. Gralow, Edith Perez, Kevin Kalinsky, Gabriel N. Hortobágyi, Nancy U. Lin +19 more

Capacity to Provide Geriatric Specialty Care for Older Adults in Community Oncology Practices

The Oncologist(2020)10.1634/theoncologist.2020-0189

N/A

0DataRank · unranked

51 citations

Kathryn E. Weaver, Glenn J. Lesser, Emily V. Dressler, Karen M. Winkfield, Heather B. Neuman +8 more

Association of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive Findings

JAMA Network Open(2020)10.1001/jamanetworkopen.2020.3842

N/A

0DataRank · unranked

48 citations

Charles D. Blanke, Michael LeBlanc, William E. Barlow, Riha Vaidya, Scott D. Ramsey +2 more

Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era

Cancer Medicine(2020)10.1002/cam4.2891

N/A

0DataRank · unranked

25 citations

Joseph M. Unger, Ann M. O’Mara, Mark A. Lewis, Troy Budd, Rebecca H. Johnson +4 more

Caregiver engagement practices in National Cancer Institute Clinical Oncology Research Program settings: Implications for research to advance the field

Cancer(2020)10.1002/cncr.33296

N/A

0DataRank · unranked

24 citations

Katherine R. Sterba, Laurie E. McLouth, Erin E. Kent, Emily V. Dressler, Alexandra Dest +11 more

A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013

Journal of Patient-Reported Outcomes(2020)10.1186/s41687-020-00220-x

N/A

0DataRank · unranked

5 citations

Joseph M. Unger, James L. Wade, Lynne I. Wagner, Mario E. Lacouture, Keisha C. Humphries +15 more

Joseph M. Unger

Indexed papers

Top data-sharing exemplar

Papers